Relmada Therapeutics
RLMD
$0.46
Share price
-5.76%
Change (1 day)
-95.42%
Change (1 year)
Categories
Market capitalization of Relmada Therapeutics (RLMD)
Market cap: NZ$13.94 Million
As of March 2025 Relmada Therapeutics has a market cap of NZ$13.94 Million. This makes Relmada Therapeutics the world's 10115th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Relmada Therapeutics from 2014 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | NZ$13.94 M | -31.96% |
| 2024 | NZ$20.49 M | -89.6% |
| 2023 | NZ$0.19 B | 19.09% |
| 2022 | NZ$0.16 B | -81.92% |
| 2021 | NZ$0.91 B | 26.04% |
| 2020 | NZ$0.72 B | -13.29% |
| 2019 | NZ$0.83 B | 1540.6% |
| 2018 | NZ$51.02 M | 285.22% |
| 2017 | NZ$13.24 M | -30.05% |
| 2016 | NZ$18.93 M | -56.79% |
| 2015 | NZ$43.82 M | -79.36% |
| 2014 | NZ$0.21 B |
End of Day market cap according to different sources
On Feb 28th, 2025 the market cap of Relmada Therapeutics was reported to be:
NZ$13.94 Million
NZ$13.94 Million
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 | NZ$2.87 B | 20,485.73% | 🇮🇱 Israel |
 | NZ$9.64 B | 69,096.21% | 🇺🇸 USA |